Realizing convenient and highly sensitive point-of-care tumor marker detection is crucial for cancer monitoring and screening. Now, researchers from the Department of Applied Physics and the Research Centre for Nanoscience and Nanotechnology at The Hong Kong Polytechnic University, led by Professor Jianhua Hao, have developed an intelligent biosensing platform based on luminescent nanoparticles and a microfluidic biochip with machine vision algorithm analysis. This innovative platform offers a new solution for the rapid and accurate detection of tumor markers such as carcinoembryonic antigen (CEA).
Why This Platform Matters
Innovative Design and Features
Experimental and Practical Validation
Future Outlook
This intelligent biosensing platform holds great promise for the future of point-of-care diagnostics. Its combination of high sensitivity, noninvasive sampling, and portable design makes it a valuable tool for early cancer screening and monitoring. Further research and development could lead to the detection of other tumor markers and broader applications in healthcare diagnostics.
Stay tuned for more breakthroughs from Professor Jianhua Hao and the team at The Hong Kong Polytechnic University!
Nano-Micro Letters
Experimental study
Intelligent Point‑of‑Care Biosensing Platform Based on Luminescent Nanoparticles and Microfluidic Biochip with Machine Vision Algorithm Analysis
14-Apr-2025